Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP2K1 | Q02750 | 17/20 | 0.60 |
| ▸ | EGFR | P00533 | 1/20 | 0.41 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.41 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.39 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4905542 | 0.90 | MAP2K1 (0.47) | MAP2K1PTGDR2 | |
| SCHEMBL4910453 | 0.89 | MAP2K1 (0.47) | MAP2K1PTGDR2 | |
| SCHEMBL4913711 | 0.88 | MAP2K1 (0.63) | MAP2K1EGFRERBB2 | |
| SCHEMBL4907892 | 0.88 | MAP2K1 (0.60) | MAP2K1 | |
| SCHEMBL4916324 | 0.87 | MAP2K1 (0.43) | MAP2K1PTGDR2 | |
| SCHEMBL4912151 | 0.87 | MAP2K1 (0.56) | MAP2K1 | |
| SCHEMBL4907775 | 0.81 | MAP2K1 (0.64) | MAP2K1 | |
| SCHEMBL4908570 | 0.81 | MET (0.53) | MAP2K1 | |
| SCHEMBL4904867 | 0.79 | MAP2K1 (0.60) | MAP2K1 | |
| SCHEMBL3692161 | 0.77 | MAP2K1 (0.96) | MAP2K1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7439246-B2 | Fused heterocyclic kinase inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2008-10-21 | — | — | US | disclosed |
| US-7439246-B2 | Fused heterocyclic kinase inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2008-10-21 | — | — | US | disclosed |
| US-7173031-B2 | Pyrrolotriazine kinase inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2007-02-06 | — | — | US | disclosed |
| US-7173031-B2 | Pyrrolotriazine kinase inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2007-02-06 | — | — | US | disclosed |